Targeting DGKA for immuno-oncology therapy: ISM4312A, a novel DGKA inhibitor with robust anti-tumor activity-MedSci.cn - 梅斯（MedSci）

Targeting DGKA for immuno-oncology therapy: ISM4312A, a novel DGKA inhibitor with robust anti-tumor activity

Sun, D; Lu, H; Yu, HX; Wang, F; Korzinkin, M; Cai, X; Ding, X; Rao, S; Ren, F; Zhavoronkov, A

CANCER RESEARCH, 2023; 83 (7):

科室
- - 订阅+
  - 更多科室
工具
服务